AMENDMENT AGREEMENTAmendment Agreement • February 15th, 2022 • AnPac Bio-Medical Science Co., Ltd. • Services-medical laboratories • New York
This Amendment Agreement (the “Agreement”), dated as of February 5, 2022, is entered into by and between Anpac Bio-Medical Science Co., Ltd., a British Virgin Islands exempted company (the “Company”), and the parties named on the signature pages hereto (each a “Holder” and collectively, the “Holders”), and amends the convertible debentures in the aggregate principal amount of $3,014,000 issued by the Company to the Holder on July 20, 2021 (the “Convertible Debentures”) pursuant to a Securities Purchase Agreement entered into between the Company and the Holders on July 20, 2021 (the “Securities Purchase Agreement”).
Debt Settlement and Mutual Release AgreementDebt Settlement and Mutual Release Agreement • February 15th, 2022 • AnPac Bio-Medical Science Co., Ltd. • Services-medical laboratories • New York
This Debt Settlement and Mutual Release Agreement (the “Agreement”) is entered into as of the date first set forth above (the “Effective Date”), by and between (i) AnPac Bio-Medical Science Co., Ltd., a British Virgin Islands company (the “Company”) and (ii) Ascent Investor Relations Inc. (“Ascent”). Each of the Company and Ascent may be referred to herein individually as a “Party” and collectively as the “Parties.”
AMENDMENT AGREEMENTAmendment Agreement • February 15th, 2022 • AnPac Bio-Medical Science Co., Ltd. • Services-medical laboratories • New York
This Amendment Agreement (the “Agreement”), dated as of February 5, 2022, is entered into by and between Anpac Bio-Medical Science Co., Ltd., a British Virgin Islands exempted company (the “Company”), and Ascent Investor Relations Inc. (the “Holder”), and amends the convertible debenture in the principal amount of $703,080 issued by the Company to the Holder on May 31, 2021 (the “Convertible Debenture”) pursuant to a Securities Purchase Agreement entered into between the Company and the Holder on May 31, 2021 (the “Securities Purchase Agreement”).
